The Scientific Profile

Dr. Diamandis’s distinguished scientific career spans over four decades of pioneering research in clinical biochemistry, molecular diagnostics, and cancer biomarker discovery. Earning his Bachelor of Science in Chemistry, Ph.D. in Analytical Chemistry, and M.D. from the University of Athens, he established a towering international reputation through his foundational research on human tissue kallikrein (KLK) gene families and prostate-specific antigen (PSA) biology.

He has authored approximately 1,000 peer-reviewed publications with over 80,000 lifetime citations and an h-index of 142, cementing his legacy as a leader in clinical proteomics and translational research. An elected Fellow of the American Association for the Advancement of Science (AAAS) and member of the national academies of Canada and Greece, Dr. Diamandis has served in prominent leadership roles, including Division Head of Clinical Biochemistry at Mount Sinai Hospital and Biochemist-in-Chief at the University Health Network.

His current scholarly focus explores multi-cancer early detection, the critical evaluation of emerging diagnostics, and the transformative integration of artificial intelligence and machine learning into empirical science and medicine. Throughout his career, he has also dedicated himself to academic mentorship, training generations of scientists while fiercely championing scientific integrity.